ARDX
Ardelyx Inc
Price:  
5.98 
USD
Volume:  
1,596,248.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx WACC - Weighted Average Cost of Capital

The WACC of Ardelyx Inc (ARDX) is 8.2%.

The Cost of Equity of Ardelyx Inc (ARDX) is 7.95%.
The Cost of Debt of Ardelyx Inc (ARDX) is 10.75%.

Range Selected
Cost of equity 6.10% - 9.80% 7.95%
Tax rate 0.40% - 0.70% 0.55%
Cost of debt 7.00% - 14.50% 10.75%
WACC 6.2% - 10.3% 8.2%
WACC

Ardelyx WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.48 0.87
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 9.80%
Tax rate 0.40% 0.70%
Debt/Equity ratio 0.13 0.13
Cost of debt 7.00% 14.50%
After-tax WACC 6.2% 10.3%
Selected WACC 8.2%

Ardelyx's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for Ardelyx:

cost_of_equity (7.95%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.48) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.